Evidence map›Paper›PMID 28553407›Full record

ArticleJournal of smoking cessation2017

Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?

Rebecca L Ashare, Caryn Lerman, Rachel F Tyndale, Larry W Hawk, Tony P George, Paul Cinciripini, Robert A Schnoll

Open access · greenAbstract read
In one paragraph

Article in Journal of smoking cessation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Nicotine receptor partial agonists for smoking cessation.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Associations Between Self-Reported Sleep Quality, Fatigue Severity, Factors Associated With Successful Cessation, and Cessation Beliefs Among Regular Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Rebecca L AshareDepartment of Psychiatry, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA, 19104.
Caryn LermanDepartment of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA, 19104.
Rachel F TyndaleCentre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, 1001 Queen Street West, Toronto, Ontario, Canada, M6J 1H4.
Larry W HawkDepartment of Psychology, State University of New York at Buffalo, Buffalo, NY, 14260.
Tony P GeorgeCentre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, 1001 Queen Street West, Toronto, Ontario, Canada, M6J 1H4.
Paul CinciripiniDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Cancer Prevention Building (Room CPB3.3309) 1155 Pressler, Houston, TX, 77030.
Robert A SchnollDepartment of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA, 19104.
University of Pennsylvania · USCentre for Addiction and Mental Health · CAThe University of Texas MD Anderson Cancer Center · USUniversity at Buffalo, State University of New York · USUniversity of Toronto · CA

Funding

University of Toronto Coordinating Genetics Core & Clinical Trial SiteU01DA020830 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CONTI, DAVID V · 2005 to 2014
$22.4M
Repurposing cholinesterase inhibitors for smoking cessationK23DA035295 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASHARE, REBECCA · 2013 to 2017
$746k
NIDA NIH HHS K23 DA035295NIDA NIH HHS U01 DA020830
6 · The paper itself

Abstract

introductionThe nicotine-metabolite ratio (NMR) predicts treatment response and is related to treatment side effect severity. Sleep disturbance may be one important side effect, but understanding sleep disturbance effects on smoking cessation is complicated by the fact that nicotine withdrawal also produces sleep disturbance.

aimsTo evaluate the effects of withdrawal and treatment side effects on sleep disturbance.

methodsThis is a secondary analysis of data from a clinical trial (Lerman et al., 2015) of 1,136 smokers randomised to placebo (

resultsThe varenicline and TN groups exhibited greater increases in sleep disturbance (vs. placebo; treatment × time interaction;

conclusionsExisting treatments may not mitigate withdrawal-related sleep disturbance and adjunctive treatments that target sleep disturbance may improve abstinence rates.

Identifiers

PMID28553407
PMCPMC5443250
OpenAlexW2338025305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.